Histrelin Acetate (Vantas®)

Common name: Histrelin Acetate
Brand name: Vantas®
 

What is Histerlin Acetate?

Histrelin Acetate is a palliative treatment for men diagnosed with hormone-dependent advanced (metastatic) prostate cancer.
 

How is Histrelin Acetate administered?

Histerlin Acetate is a placed under the skin (subcutaneous) as a subdermal implant.
 

What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received histrelin. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Abdominal pain
  • Dark urine
  • Difficulties breathing
  • Local infection
  • Loss of appetite
  • Nausea
  • Reduced testicle size
  • Vomiting
  • Weight gain
 

Is histrelin acetate covered in my province or territory?

Provincial/Territorial Drug Program Coverage: Unknown 
 

 
Last Reviewed: July 2017

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive